| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024059 |
| Receipt No. | R000027416 |
| Official scientific title of the study | Predictors of stent dysfunction after self-expandable metal stent placement for malignant gastric outlet obstruction |
| Date of disclosure of the study information | 2016/09/14 |
| Last modified on | 2017/03/15 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Predictors of stent dysfunction after self-expandable metal stent placement for malignant gastric outlet obstruction | |
| Title of the study (Brief title) | Predictors for stent dysfunction in GOO | |
| Region |
|
|
| Condition | |||
| Condition | Malignant gastric outlet obstruction (GOO) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate predictors of stent dysfunction, especially stent ingrowth in uncovered self-expandable metallic stent (U-SEMS) and migration in covered self-expandable metallic stent (C-SEMS), those are main causes of stent dysfunction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To claryfy the predictors of stent dysfunction. |
| Key secondary outcomes | Investigate the predictors of stent ingrowth in U-SEMS and migration in C-SEMS. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Malignant gastric outlet obstruction (GOO) patients, who consent to participate in the study in Nagoya City University Hospital and research cooperation facilities | |||
| Key exclusion criteria | Not obtained the consent | |||
| Target sample size | 252 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuki Hori |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Division name | Department of Gastroenterology and Metabolism |
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya Japan |
| TEL | +81-52-853-8211 |
| yhori@med.nagoya-cu.ac.jp | |
| Public contact | |
| Name of contact person | Itaru Naitoh |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Division name | Department of Gastroenterology and Metabolism |
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya Japan |
| TEL | +81-52-853-8211 |
| Homepage URL | |
| inaito@med.nagoya-cu.ac.jp | |
| Sponsor | |
| Institute | Nagoya City University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Nagoya Daini Red cross Hospital,
Gifu Prefectural Tajimi Hospital, Kasugai Municipal Hospital, Nagoya City West Medical Center Toyokawa City Hospital Japan Community Health Care Organization Midori Municipal Hospital Gamagori City Hospital |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋第二赤十字病院(愛知県)、岐阜県立多治見病院(岐阜県)、春日井市民病院(愛知県)、名古屋市西部医療センター(愛知県)、豊川市民病院(愛知県)、中京病院(愛知県)、緑市民病院(愛知県)、蒲郡市民病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.ncbi.nlm.nih.gov/pubmed/28281116 |
| Results | Both U-SEMS and C-SEMS are effective with comparable patencies. Tumor ingrowth and stent migration are the main causes of stent dysfunction for U-SEMS and C-SEMS, respectively. With regard to stent dysfunction, U-SEMS might be a good option for patients receiving chemotherapy, while C-SEMS with longer stents for patients in good condition. |
| Other related information | Samples are collected from subjects who participated in this study in Nagoya City University Hospital and research affiliated facilities.
Samples and clinical information without containing personal information are numbered and managed in Nagoya City University Hospital. Consecutive paitents who underwent metallic stenting for malignant gastric outlet obstruction in affiliated institutions from 2004. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027416 |